Ketamine, an inhibitor of lysine acetyltransferase 5 (KAT5), inhibits GPX4 by decreasing the levels of H3K27ac, leading to the execution of ferroptosis in breast cancer [136]. This evidence concerns the gene KAT5 and breast carcinoma.